Publication:
Effects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activity

dc.contributor.authorSurasak Taneepanichskulen_US
dc.contributor.authorSanya Patrachaien_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-04T08:09:46Z
dc.date.available2018-07-04T08:09:46Z
dc.date.issued1998-12-01en_US
dc.description.abstractThe aims of this study were to evaluate the serum estradiol level and the estrogenic activity in long-term DMPA users. From 1st January 1996 to 31st December 1996, fifty healthy women receiving DMPA for contraception for more than 36 months were recruited to the study. From the study, it was found that the mean duration of DMPA use was 59.1±30.7 months, the mean serum estradiol was 52.7±15.1 pg/ml and these women did not have problems of estrogen deficiency. This study revealed that long-term treatment with DMPA should not have any adverse effects on estrogenic activity.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.81, No.12 (1998), 943-946en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-0040811029en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/18446
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0040811029&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEffects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activityen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0040811029&origin=inwarden_US

Files

Collections